Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock		Additional Paid-In Capital	Accumulated Other Comprehensive Loss		Retained Earnings	Treasury Stock		Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 26, 2021			35,797
Beginning balance at Dec. 26, 2021		$ (172,458)	$ 490		$ 445,126	$ (9,971)	[1]	$ 183,157	$ (806,472)		$ 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	45,062						44,258			804
Other comprehensive income (loss), net of tax		(3,897)				(3,897)	[1]
Dividends on common stock		(39,976)			153			(40,129)
Exercise of stock options (in shares)			55
Exercise of stock options		$ 2,731	$ 1		2,730
Acquisition of Company common stock (in shares)		(982)	(982)
Acquisition of Company common stock		$ (95,000)							(95,000)
Stock-based compensation expense		14,246			14,246
Issuance of restricted stock (in shares)			279
Issuance of restricted stock		88			(8,122)				8,210
Tax effect of restricted stock awards (in shares)			(92)
Tax effect of restricted stock awards		(9,426)			(9,426)
Distributions to noncontrolling interests		(366)									(366)
Other (in shares)			8
Other		377			(64)				444		(3)
Ending balance (in shares) at Sep. 25, 2022			35,065
Ending balance at Sep. 25, 2022		(258,619)	$ 491		444,643	(13,868)	[1]	187,286	(892,818)		15,647
Beginning balance (in shares) at Jun. 26, 2022			35,248
Beginning balance at Jun. 26, 2022		(233,798)	$ 491		442,255	(11,034)	[1]	193,934	(875,205)		15,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	8,433						8,331			102
Other comprehensive income (loss), net of tax		(2,834)				(2,834)	[1]
Dividends on common stock		(14,922)			57			(14,979)
Exercise of stock options (in shares)			16
Exercise of stock options		$ 823			823
Acquisition of Company common stock (in shares)		(229)	(229)
Acquisition of Company common stock		$ (19,529)							(19,529)
Stock-based compensation expense		5,146			5,146
Issuance of restricted stock (in shares)			50
Issuance of restricted stock		89			(1,671)				1,760
Tax effect of restricted stock awards (in shares)			(22)
Tax effect of restricted stock awards		(1,900)			(1,900)
Distributions to noncontrolling interests		(216)									(216)
Other (in shares)			2
Other		89			(67)				156
Ending balance (in shares) at Sep. 25, 2022			35,065
Ending balance at Sep. 25, 2022		$ (258,619)	$ 491		444,643	(13,868)	[1]	187,286	(892,818)		15,647
Beginning balance (in shares) at Dec. 25, 2022		34,700	34,736
Beginning balance at Dec. 25, 2022		$ (270,664)	$ 491		449,829	(10,135)	[3]	195,856	(922,434)	[4]	15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	56,221						56,005			216
Other comprehensive income (loss), net of tax		2,219				2,219	[3]
Dividends on common stock		(43,641)			88			(43,729)
Exercise of stock options (in shares)			35
Exercise of stock options		$ 1,817	$ 1		1,816
Acquisition of Company common stock (in shares)		(2,523)	(2,523)	[4]
Acquisition of Company common stock		$ (212,444)							(212,444)	[4]
Stock-based compensation expense		13,224			13,224
Issuance of restricted stock (in shares)			234
Issuance of restricted stock		0			(6,857)				6,857	[4]
Tax effect of restricted stock awards (in shares)			(75)
Tax effect of restricted stock awards		(6,279)			(6,279)
Distributions to noncontrolling interests		(651)									(651)
Other (in shares)			66
Other		$ 300			(4,122)				4,422	[4]
Ending balance (in shares) at Sep. 24, 2023		32,500	32,473
Ending balance at Sep. 24, 2023		$ (459,898)	$ 492		447,699	(7,916)	[3]	208,132	(1,123,599)	[4]	15,294
Beginning balance (in shares) at Jun. 25, 2023			32,394
Beginning balance at Jun. 25, 2023		(465,479)	$ 492		445,964	(7,289)	[3]	207,461	(1,127,669)	[4]	15,562
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	15,921						15,861			60
Other comprehensive income (loss), net of tax		(627)				(627)	[3]
Dividends on common stock		(15,156)			34			(15,190)
Exercise of stock options (in shares)			18
Exercise of stock options		$ 1,134			1,134
Acquisition of Company common stock (in shares)		0
Stock-based compensation expense		$ 4,726			4,726
Issuance of restricted stock (in shares)			7
Issuance of restricted stock		0			(315)				315	[4]
Tax effect of restricted stock awards (in shares)			(2)
Tax effect of restricted stock awards		(171)			(171)
Distributions to noncontrolling interests		(328)									(328)
Other (in shares)			56
Other		$ 82			(3,673)				3,755	[4]
Ending balance (in shares) at Sep. 24, 2023		32,500	32,473
Ending balance at Sep. 24, 2023		$ (459,898)	$ 492		$ 447,699	$ (7,916)	[3]	$ 208,132	$ (1,123,599)	[4]	$ 15,294

[1] At September 25, 2022, the accumulated other comprehensive loss of $13,868 was comprised of net unrealized foreign currency translation loss of $12,430 and net unrealized loss on the interest rate swap agreements of $1,438.

[2] Net income to the Company for the three and nine months ended September 25, 2022 excludes $31 and $559, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

[3] At September 24, 2023, the accumulated other comprehensive loss of $7,916 was comprised of net unrealized foreign currency translation loss of $8,702 and net unrealized gain on the interest rate swap agreements of $786.

[4] Acquisition of Company common stock for the nine months ended September 24, 2023 includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.

[5] Net income to the Company for the three and nine months ended September 24, 2023 excludes $30 and $135, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.